ストックスクリーナーアプリを入手
1.02
0.97%
-0.01
前日終値:
$1.03
開ける：
$1.04
24時間の取引高:
22,775
Relative Volume:
0.66
時価総額：
$19.65M
収益：
$225.00K
当期純損益:
$-8.83M
株価収益率:
-1.395
EPS:
-0.7312
ネットキャッシュフロー:
$-8.01M
1週間 パフォーマンス:
-4.67%
1か月 パフォーマンス:
-10.53%
6か月 パフォーマンス:
-35.03%
1年 パフォーマンス:
-4.67%
1日の値動き範囲:
$1.01
$1.0598
1週間の範囲:
$1.01
$1.1099
52週間の値動き範囲:
$0.76
$2.0299
Cocrystal Pharma Inc Stock (COCP) Company Profile
名前
Cocrystal Pharma Inc
セクター
電話
(786) 459-1831
住所
19805 N. CREEK PARKWAY, BOTHELL, WA
Compare COCP vs VRTX, MRNA, REGN, ARGX, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
COCP
Cocrystal Pharma Inc
|
1.02 | 19.65M | 225.00K | -8.83M | -8.01M | -0.7312 |
VRTX
Vertex Pharmaceuticals Inc
|
499.74 | 126.66B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
218.01 | 87.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
790.74 | 81.41B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
819.14 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
369.06 | 41.75B | 5.76B | 514.49M | 1.10B | 4.4813 |
Cocrystal Pharma Inc Stock (COCP) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2020-07-08 | 開始されました | H.C. Wainwright | Buy |
Cocrystal Pharma Inc (COCP) 最新ニュース
H.C. Wainwright reiterates Cocrystal Pharma stock rating at buy By Investing.com - Investing.com South Africa
H.C. Wainwright reiterates Cocrystal Pharma stock rating at buy By Investing.com - Investing.com Canada
H.C. Wainwright reiterates Cocrystal Pharma stock rating at buy - Investing.com
AIM ImmunoTech Inc. (AIM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Daré Bioscience, Inc. (DARE) stock price, news, quote and history - Yahoo Finance UK
Daré Bioscience, Inc. (DARE) Stock Price, News, Quote & History - ca.finance.yahoo.com
Cocrystal Pharma (COCP) Jumps 8.47% to $1.28 as Biotech Stock Approaches ResistanceHigh Yield Stocks - dars.gov.et
Cocrystal Pharma Completes Dosing in Norovirus Phase 1b Study - TipRanks
Cocrystal Pharma (COCP) Advances Norovirus Antiviral Study Amid High Price-to-Sales Valuation - GuruFocus
Cocrystal Pharma (COCP) finishes dosing human norovirus study, eyes first efficacy readout next - Stock Titan
Cocrystal completes dosing in norovirus drug trial By Investing.com - Investing.com India
Cocrystal completes dosing in norovirus drug trial By Investing.com - Investing.com UK
No serious adverse events reported as a norovirus drug study reaches final dosing - Stock Titan
Cocrystal Pharma (COCP) Jumps 8.47% to $1.28 as Biotech Stock Approaches ResistanceNew Highs New Lows - dars.gov.et
Cocrystal Pharma (COCP) Jumps 8.47% to $1.28 as Biotech Stock Approaches ResistanceLong Setup Ideas - dars.gov.et
symbol__ Stock Quote Price and Forecast - cnn.com
Cocrystal Pharma: The Strategic Reset Investors May Be Missing - Yahoo Finance
Cocrystal Pharma Inc. (COCP) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Cocrystal (COCP) director Brosgart files with zero reported holdings - Stock Titan
COCP: 5 Million Private Placement with OPKO Health - Smartkarma
Cocrystal (COCP) Q1 2026 Results: The EPS Result Is Below Expectation in the Reported Period; After Earnings: The Share Price Adds 0.87%Dividend Increase Stocks - vinanet.vn
Cocrystal Pharma (NasdaqCM:COCP) Stock Forecast & Analyst Predictions - Simply Wall Street
Stock Options: Choosing The Right Viral Inoculum For An Early-Phase Norovirus Trial - Clinical Leader
Cocrystal Pharma appoints Carol L. Brosgart to board of directors By Investing.com - Investing.com South Africa
Cocrystal Pharma appoints Carol L. Brosgart to board of directors By Investing.com - Investing.com South Africa
Form 8K Cocrystal Pharma Inc For: 18 August By Investing.com - Investing.com Nigeria
Cocrystal Pharma appoints Carol L. Brosgart to board of directors By Investing.com - Investing.com India
Cocrystal Pharma appoints Carol L. Brosgart to board of directors - Investing.com
Cocrystal Pharma appoints Carol L. Brosgart to board of directors - Investing.com
Cocrystal Pharma Adds Veteran Leader to Board of Directors - TipRanks
Form 8K Cocrystal Pharma Inc For: 18 August By Investing.com - Investing.com India
Form 8K Cocrystal Pharma Inc For: 18 August By Investing.com - Investing.com Canada
Form 8K Cocrystal Pharma Inc For: 18 August By Investing.com - Investing.com UK
Cocrystal Pharma (NASDAQ: COCP) names Carol L. Brosgart to its board - Stock Titan
Cocrystal Pharma strengthens board with antiviral expert appointment - TipRanks
Cocrystal Pharma appoints Carol Brosgart to board to bolster antiviral development - TradingView
Cocrystal Pharma (COCP) appoints antiviral veteran to board - Stock Titan
Cocrystal Pharma Appoints Antiviral Drug Expert Carol Brosgart to Board - citybiz
Cocrystal Pharma appoints Carol Brosgart to board of directors By Investing.com - Investing.com Nigeria
Cocrystal Pharma appoints Carol Brosgart to board of directors By Investing.com - Investing.com South Africa
Cocrystal Pharma appoints Carol Brosgart to board of directors - Investing.com
Cocrystal Pharma appoints Carol Brosgart to board of directors By Investing.com - Investing.com Canada
Cocrystal Pharma Appoints Carol Brosgart, MD to its Board of Directors - The Manila Times
Cocrystal Pharma Appoints Carol Brosgart, M.D. to Board of Directors - Quiver Quantitative
A Gilead veteran joins Cocrystal’s board to guide antiviral drug development - Stock Titan
Cocrystal Pharma Appoints Carol Brosgart, M.D. to Board of Directors - Quiver Quantitative
COCP Q1 2026 Earnings: Wider-than-Expected Loss Costs Share PriceEnergy Earnings Report - careplusvn.com
Cocrystal Pharma Appoints Carol Brosgart, M.D. to Board of Directors - Quiver Quantitative
Cocrystal Pharma Q2 Results: EPS Loss Widens to $(0.23), Misses Estimate - scanx.trade
Cocrystal Pharma Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Cocrystal Pharma Inc (COCP) 財務データ
収益
当期純利益
現金流量
EPS
Cocrystal Pharma Inc (COCP) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| FROST PHILLIP MD ET AL | Director |
Aug 03 '26 |
Buy |
0.94 |
75,000 |
70,590 |
1,983,551 |
| FROST PHILLIP MD ET AL | Director |
Feb 24 '26 |
Buy |
1.00 |
20,000 |
19,952 |
1,908,551 |
| FROST PHILLIP MD ET AL | Director |
Feb 06 '26 |
Buy |
0.95 |
50,000 |
47,280 |
1,888,551 |
| FROST PHILLIP MD ET AL | Director |
Dec 31 '25 |
Buy |
0.95 |
50,000 |
47,275 |
1,838,551 |
| FROST PHILLIP MD ET AL | Director |
Dec 30 '25 |
Buy |
0.97 |
20,000 |
19,310 |
1,788,551 |
| FROST PHILLIP MD ET AL | Director |
Dec 26 '25 |
Buy |
0.97 |
40,000 |
38,944 |
1,768,551 |
| FROST PHILLIP MD ET AL | Director |
Dec 24 '25 |
Buy |
0.97 |
25,000 |
24,258 |
1,728,551 |
| FROST PHILLIP MD ET AL | Director |
Nov 26 '25 |
Buy |
0.99 |
4,000 |
3,975 |
1,703,551 |
| FROST PHILLIP MD ET AL | Director |
Nov 25 '25 |
Buy |
0.94 |
20,000 |
18,812 |
1,699,551 |
4.22%
大文字化:
|
ボリューム (24 時間):